Related Experiment Videos
Salazopyrin-induced eosinophilic pneumonia
Respiration; International Review of Thoracic Diseases
|January 1, 1985
Summary
A patient developed eosinophilic pneumonia while taking Salazopyrin for ulcerative colitis. Steroid treatment resolved the condition, indicating a drug-induced side effect.
Area of Science:
- Pulmonology
- Gastroenterology
- Clinical Pharmacology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
- Salazopyrin (sulfasalazine) is a common medication for UC treatment.
- Eosinophilic pneumonia is a rare lung condition characterized by the accumulation of eosinophils in the lungs.
Observation:
- A patient with UC experienced adverse respiratory symptoms during Salazopyrin therapy.
- The patient was diagnosed with eosinophilic pneumonia.
- Symptoms improved upon Salazopyrin withdrawal and corticosteroid initiation.
Findings:
- Recurrence of eosinophilic pneumonia was observed upon attempting to discontinue prednisolone.
- Definitive resolution of symptoms occurred with sustained prednisolone treatment.
- This suggests a direct link between Salazopyrin and drug-induced eosinophilic pneumonia, managed by corticosteroids.
Implications:
- Highlights the potential for Salazopyrin to cause eosinophilic pneumonia in UC patients.
- Underscores the importance of considering drug-induced lung disease in patients with UC.
- Demonstrates the efficacy of corticosteroid therapy in managing this adverse reaction.